
Successful heart transplantation for COVID‐19‐associated post‐infectious fulminant myocarditis
Author(s) -
Gaudriot Baptiste,
Mansour Alexandre,
Thibault Vincent,
Lederlin Mathieu,
Cauchois Aurélie,
Lelong Bernard,
Ross James T.,
Leurent Guillaume,
Tadié JeanMarc,
Revest Matthieu,
Verhoye JeanPhilippe,
Flecher Erwan,
Nesseler Nicolas
Publication year - 2021
Publication title -
esc heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.787
H-Index - 25
ISSN - 2055-5822
DOI - 10.1002/ehf2.13326
Subject(s) - medicine , fulminant , myocarditis , extracorporeal membrane oxygenation , heart transplantation , cardiology , transplantation , heart failure , viral myocarditis , infectious disease (medical specialty) , intensive care medicine , disease
Various clinical presentations of the 2019 coronavirus disease (COVID‐19) have been described, including post‐infectious acute and fulminant myocarditis. Here, we describe the case of a young patient admitted for COVID‐19‐associated post‐infectious fulminant myocarditis. Despite optimal pharmacologic management, haemodynamic status worsened requiring support by veno‐arterial extracorporeal membrane oxygenation. Emergent heart transplantation was required at Day 11 given the absence of cardiac function improvement. The diagnosis of post‐infectious COVID‐19‐associated myocarditis was made from both pathologic examination of the explanted heart and positive SARS‐CoV‐2 serology.